Ono Pharma Partners with Mediar to Develop Novel Fibrosis Antibodies
OSAKA, Japan & BOSTON, Mass., August 6, 2026 Ono Pharmaceutical Co., Ltd. announced a drug discovery partnership and option...
fibrosis therapy
Advertisement
MetaVia Highlights Vanoglipel’s MASH Fibrosis Potential
CAMBRIDGE, Mass., May 20, 2026 MetaVia Inc. has announced the publication of new peer-reviewed preclinical research supporting the anti-fibrotic...
Oorja Bio Reports Positive Phase 1 Data for ORJ-001 in IPF
HOUSTON, Texas, May 19, 2026 Oorja Bio announced positive first-in-human Phase 1 clinical data for ORJ-001, a first-in-class peptide...
Gyre Therapeutics Advances Fibrosis-First Pipeline with Strong Q3 Growth and Regulatory Momentum
Dateline — San Diego, California, November 7, 2025:Gyre Therapeutics, Inc. (NASDAQ: GYRE) reported Q3 2025 financial results and a...
Advertisement
